When did BIOCERES CROP SOLUTIONS CORP (BIOX) report earnings last quarter?
BIOCERES CROP SOLUTIONS CORP (BIOX) last reported earnings on 3/13/2026.
BIOCERES CROP SOLUTIONS CORP (BIOX) Earnings History & Surprises
NASDAQ:BIOX • KYG1117K1141
Current stock price
0.5579 USD
+0.02 (+3.26%)
At close:
0.57 USD
+0.01 (+2.17%)
After Hours:
BIOX Earnings overview
Past quarterly earnings results for BIOCERES CROP SOLUTIONS CORP (BIOX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- N/A
- Period
- Q3 / 2026
- EPS Estimate
- -$0.05
- Revenue Estimate
- 55.59M
Last Reported
Most Recent- Release Date
- Mar 13, 2026
- Period
- Q2 / 2026
- EPS Reported
- -$0.08
- EPS Surprise
- -212.04%
- Revenue Surprise
- -24.73%
Beat Rate
Last 8 Quarters 6%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | -0.08 | 0.07 | -212.04% | -988.89% | 73.7M | 97.92M | -24.73% | -30.99% |
| Q1 2026 | -0.12 | -0.07 | -62.27% | -33.33% | 77.3M | 92.03M | -16.01% | -16.52% |
| Q4 2025 | -0.70 | 0.08 | -1,015.03% | -2,233.33% | 74.7M | 113.91M | -34.42% | -39.76% |
| Q3 2025 | -0.02 | -0.15 | 86.93% | -114.29% | 60.6M | 65.212M | -7.07% | -27.86% |
| Q2 2025 | 0.01 | 0.09 | -89.82% | -52.63% | 106.8M | 132.09M | -19.15% | -23.82% |
| Q1 2025 | -0.09 | -0.01 | -1,076.47% | -28.57% | 92.6M | 111.44M | -16.91% | -20.58% |
| Q4 2024 | -0.03 | 0.25 | -112.05% | 50.00% | 124M | 138.07M | -10.19% | 18.43% |
| Q3 2024 | 0.14 | 0.17 | -19.26% | -68.18% | 84M | 100.47M | -16.39% | -10.26% |
| Q2 2024 | 0.02 | 0.09 | -79.75% | 113.57% | 140.2M | 119.33M | 17.49% | 50.75% |
| Q1 2024 | -0.07 | 0.06 | -219.35% | -975.00% | 116.6M | 126.29M | -7.67% | -7.90% |
| Q4 2023 | -0.06 | 0.05 | -227.88% | 27.71% | 104.7M | 109.81M | -4.65% | 1.16% |
| Q3 2023 | 0.44 | -0.03 | 1,759.13% | 378.48% | 93.605M | 90.181M | 3.80% | 38.88% |
| Q2 2023 | -0.14 | 0.07 | -303.34% | -275.00% | 93M | 93.824M | -0.88% | 2.09% |
| Q1 2023 | 0.01 | 0.05 | -83.66% | -60.00% | 126.6M | 83.63M | 51.38% | 90.66% |
| Q4 2022 | -0.08 | 0.16 | -150.86% | -515.00% | 103.5M | 96.792M | 6.93% | 27.62% |
| Q3 2022 | -0.16 | -0.08 | -99.87% | -409.68% | 67.4M | 45.631M | 47.71% | 89.86% |
| Q2 2022 | 0.08 | 0.05 | 49.39% | 370.59% | 91.1M | 71.384M | 27.62% | 89.79% |
| Q1 2022 | 0.02 | 0.09 | -78.80% | 110.53% | 66.4M | 51.214M | 29.65% | 57.72% |
| Q4 2021 | 0.02 | 0.27 | -92.60% | -66.67% | 81.1M | 55.007M | 47.44% | 68.61% |
| Q3 2021 | -0.03 | -0.05 | 39.22% | 65.56% | 35.5M | 27.967M | 26.94% | 38.13% |
| Q2 2021 | 0.02 | 0.37 | -95.37% | -94.52% | 48M | 68.952M | -30.39% | -22.95% |
| Q1 2021 | -0.19 | 0.08 | -332.84% | -111.11% | 42.1M | 40.8M | 3.19% | 15.98% |
| Q4 2020 | 0.06 | 0.22 | -72.64% | - | 48.1M | 50.813M | -5.34% | - |
| Q3 2020 | -0.09 | -0.12 | 23.27% | - | 25.7M | 20.4M | 25.98% | - |
| Q2 2020 | 0.31 | 0.34 | -7.90% | - | 62.3M | 71.4M | -12.75% | - |
| Q1 2020 | -0.09 | - | - | 36.3M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-300.61%
Max EPS beat (4)
86.93%
Min EPS beat (4)
-1,015.03%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-20.56%
Max Revenue beat (4)
-7.07%
Min Revenue beat (4)
-34.42%
Analysis
In the last 4 quarters, BIOX has beaten EPS estimates in 1 out of 4 releases
BIOX has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, BIOX reported -300.6% below the EPS estimates on average.
In the last 4 quarters, BIOX reported -20.6% below the revenue estimates on average.
Related analysis
BIOCERES CROP SOLUTIONS CORP / BIOX Earnings FAQ
Can you provide information on whether BIOCERES CROP SOLUTIONS CORP beat earnings estimates in the last quarter?
BIOCERES CROP SOLUTIONS CORP (BIOX) missed EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does BIOX stock beat earnings estimates?
In the last 4 quarters, BIOCERES CROP SOLUTIONS CORP (BIOX) has beaten EPS estimates in 1 out of 4 releases.